PL2 Big Data Discoveries and Clinical Advances in Adrenal Disease

Program: Plenary
Translational Session
Friday, April 1, 2016: 3:30 PM-4:30 PM
Hall B2 (BCEC)

One Nobel prize-winning corticoid to thousands:  The new Omics of adrenal biology and disease

3:30 PM
Lisa H Fish, MD, Hennepin County Medical Ctr, Edina, MN
Nothing to Disclose: LHF
3:40 PM
Wiebke Arlt, MD, DSc, FRCP, FMedSci, IMSR Inst of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom
Disclosures:
WA: Holder of a patent, Abingdon Health.
4:05 PM
Deborah P. Merke, MS, MD, Clinical Center, NIH, Bethesda, MD
Disclosures:
DPM: Principal Investigator, Diurnal.
See more of: Plenary

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire